Main content
A Risk Worth Taking?
Shelley Jofre investigates the drug Avandia and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.
We're in the grip of a diabetes epidemic. The NHS spent more than half a billion pounds on medication for it in 2009. Patients trust that these drugs are safe, but does one come with a hidden cost to health? Shelley Jofre investigates the rise and fall of Avandia, until recently one of the UK's best-selling diabetes drugs, and asks whether the medicine's regulator is putting the interests of the drugs industry before patients.
Last on
Sun 12 Sep 2010
20:30
大象传媒 News UK
More episodes
Previous
Next
Credits
| Role | Contributor |
|---|---|
| Presenter | Jeremy Vine |
| Producer | Angie Mason |
| Reporter | Shelley Jofre |
Explore the wider challenges that people with a learning disability face in society, and how this impacts on their health
Find out more with The Open University.